ELAN
Elanco Animal Health IncorporatedPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #311
- Final score
- 57.48
- Years on list
- 6
↗ Climbed 553 since 2020
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- ELAN· Elanco Animal Health Incorporated
- AMGN· Amgen Inc.
- BMY· Bristol-Myers Squibb Company
Figure 01 · Side-by-side summary
The headline numbers
AMGN
Amgen Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #295
- Final score
- 58.02
- Years on list
- 6
↘ Down 133 since 2020
BMY
Bristol-Myers Squibb CompanyPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #318
- Final score
- 57.23
- Years on list
- 6
↘ Down 237 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | ELAN | AMGN | BMY |
|---|---|---|---|
| Climate Change | 60.6 | 64.4 | 73.2 |
| Employee Relations | 48.3 | 47.2 | 39.9 |
| Environment | 61.6 | 64.0 | 45.6 |
| Stakeholders & Society | 63.9 | 66.7 | 73.4 |
| Human Rights | 65.2 | 37.4 | 58.0 |
| Governance | 49.9 | 60.9 | 50.5 |
| Performance Rating | 43.2 | 68.3 | 68.4 |